We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cassava Sciences Inc | NASDAQ:SAVA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 22.05 | 22.10 | 22.30 | 428 | 12:18:11 |
Event details follow: | |
Date: | Monday, September 14th |
Time: | 8:30 a.m. Eastern Time |
Audio Webcast: | https://www.CassavaSciences.com/company-presentations |
Dial-In: | 1-800-920-4315 |
Conference ID: | 21969265 |
The dial-in number for international callers is 1-212-231-2929. A replay of the webcast will remain available in the ‘Investors’ section of Cassava Sciences’ website, www.CassavaSciences.com, for 90 days following the conference. In addition, a telephonic replay of the call will be available until September 28, 2020. The replay dial-in numbers are 1-844-512-2921 for domestic callers and 1-412-317-6671 for international callers. Please use the replay conference ID number 21969265.
About Cassava Sciences, Inc.Cassava Sciences’ mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer’s disease. Cassava Sciences owns worldwide development and commercial rights to its research programs in Alzheimer’s disease, and related technologies, without royalty obligations to any third-party.
For More Information Contact:Eric Schoen, Chief Financial OfficerCassava Sciences, Inc.eschoen@CassavaSciences.com(512) 501-2450
1 Year Cassava Sciences Chart |
1 Month Cassava Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions